PAR 3.33% 21.8¢ paradigm biopharmaceuticals limited..

PAR. SP, page-463

  1. 1,690 Posts.
    lightbulb Created with Sketch. 184
    Hotpy, I think most of the pre revenue (especially
    bio) company managements grossly exaggerate
    their prospects of success. When reality sets in,
    the inevitable share price adjustment occurs.
    Every biotech I have as a shareholder is guilty of
    this. In the case of PAR it is mostly about overly
    optimistic timelines, with an eye on the next CR.

    It has been said before, but you can only “cry
    wolf” so many times before people lose trust
    and take what comes out of PR’s mouth as
    very unreliable.

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
21.8¢
Change
-0.008(3.33%)
Mkt cap ! $77.86M
Open High Low Value Volume
23.0¢ 23.0¢ 21.8¢ $59.19K 265.2K

Buyers (Bids)

No. Vol. Price($)
9 106607 21.5¢
 

Sellers (Offers)

Price($) Vol. No.
22.0¢ 6245 2
View Market Depth
Last trade - 12.20pm 11/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.